September 11, 2018
The Federal Circuit's decision Monday rejecting the University of California's efforts to secure control over patents on the breakthrough gene-editing system CRISPR in a fight with the Broad Institute leaves an unsettled patent landscape for the technology that could spur the parties to strike a deal, attorneys say.
September 10, 2018
The Federal Circuit on Monday rejected the University of California's bid for control over patents on the breakthrough gene-editing system CRISPR, turning away its challenge to patents on the technology to issued to a research institute associated with Harvard and MIT.
April 30, 2018
Researchers from the University of California, Berkeley and the University of Vienna fended off pointed questioning Monday from a Federal Circuit panel on their effort to nix a patent for gene-editing technology CRISPR-Cas9, held by the Massachusetts-based Broad Institute.
July 26, 2017
The University of California urged the Federal Circuit Tuesday to overturn a Patent Trial and Appeal Board decision favoring a research institute associated with Harvard and MIT in a hotly contested patent dispute over the breakthrough gene-editing technology CRISPR, calling the ruling “profoundly erroneous” and "unjust."
April 13, 2017
Researchers from the University of California, Berkeley and the University of Vienna have appealed a Patent Trial and Appeal Board decision finding no overlap between their CRISPR patents and those of the Massachusetts-based Broad Institute, furthering the IP battle between elite teams of scientists over the revolutionary gene-editing technology.